Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer

NCT02229149 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped per Sponsor request

Conditions

Breast Neoplasms
Malignant Tumor of the Breast

Interventions

DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Vinorelbine, Paclitaxel, Nab-Paclitaxel , Docetaxel, Capecitabine

Sponsor

US Oncology Research

Collaborators

[object Object]